Physician profile
Farid Jalinous
NPI 1093717282
$6,819.07
in general payments reported to CMS, 2019-2025
39 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $328 · 2021: $280 · 2022: $682 · 2023: $1,755 · 2024: $1,136 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,552 · Travel and Lodging: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,551.53 |
| Travel and Lodging | $582.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,697.53 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $969.82 | 2019-2025 | |
| Boston Scientific Corporation | $565.06 | 2019-2025 | General - Balloon Catheters, Watchman Flx, Emblem Mri S-Icd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $405.19 | 2019-2025 | Lifevest |
| Abbott Laboratories | $374.09 | 2019-2024 | Cardiomems |
| Pfizer INC. | $325.60 | 2022-2025 | |
| Medtronic, INC. | $292.73 | 2021-2025 | Symplicity G3, Abre, Spiderfx |
| Janssen Pharmaceuticals, INC | $271.94 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $210.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $180.23 | 2020-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $172.98 | 2022-2023 | Verquvo |
| Medtronic Vascular, INC. | $132.63 | 2019 | |
| Endologix LLC | $104.43 | 2019 | |
| Shockwave Medical, INC | $95.52 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $95.29 | 2020-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $93.63 | 2022 | |
| Angiodynamics, INC. | $75.16 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Scpharmaceuticals INC. | $72.24 | 2024-2025 | |
| Teleflex LLC | $56.77 | 2023-2025 | Vascband, Guideliner |
| Penumbra, INC. | $56.24 | 2021-2024 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.74 | 2023 | Jardiance |
| Cardiva Medical, INC. | $46.31 | 2021-2022 | |
| Imperative Care, INC | $45.77 | 2025 | Prodigy Catheter, Symphony Catheter |
| Baxter Healthcare | $45.60 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| W. L. Gore & Associates, INC. | $42.66 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $41.78 | 2021-2025 | Trek |
| Astrazeneca Pharmaceuticals LP | $39.58 | 2020-2022 | |
| Amgen INC. | $39.15 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $34.20 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $29.57 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Gilead Sciences, INC. | $27.74 | 2019 | |
| Elutia, INC. | $20.72 | 2022 | |
| Argon Medical Devices, INC. | $20.22 | 2023 | Ivcf |
| Terumo Medical Corporation | $17.31 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.22 | 2023 | Inpefa |
| Cathworks, INC. | $14.64 | 2025 | Ffrangio |
| Esperion Therapeutics, INC. | $13.23 | 2022 | |
| Biotronik INC. | $13.20 | 2024 | Pk Papyrus, Orsiro Mission |
| Ethicon US, LLC | $13.08 | 2024 | Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Jalinous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.